Skip to main content
. 2019 Apr 1;17:106. doi: 10.1186/s12967-019-1858-7

Fig. 2.

Fig. 2

Allo-HSCT overcomes the adverse prognostic influence of high miR-363 expression in AML. a The 162 cases were divided into two groups according to median miR-363 levels. Kaplan–Meier survival curves for cases administered chemotherapy (n = 53) and allo-HSCT (n = 28), respectively, in the high miR-363 group. b Kaplan–Meier survival curves for cases administered chemotherapy (n = 37) and allo-HSCT (n = 44), respectively, in the low miR-363 group